Search

everythinglearnresearchcommunity

for

Search:↓

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

The document suggests "anisotrichosis" as a new term for hair thickness variation in common baldness.

The research found no clear link between the severity of male baldness and the scalp examination findings in Indonesian men.

Different levels of microRNAs in different parts of the scalp can cause male pattern baldness.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

A new method using Platelet-rich Plasma (PRP) in a microneedle can promote hair regrowth more efficiently and is painless, minimally invasive, and affordable.

Organotypic culture systems can grow skin tissues that mimic real skin functions and are useful for skin disease and hair growth research, but they don't fully replicate skin complexity.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Polymeric nanoparticles could improve hair loss treatments by delivering drugs more effectively to hair follicles.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Review determines effective, safe treatments for female hair loss.

Collagen peptides from marine and bovine sources may help prevent hair loss by affecting hair follicle stem cells differently.

New treatments for hair loss, including a compound called "ALRV5XR", platelet-rich plasma, and Adult Stem Cell-based therapy, are showing promise, but more trials are needed for confirmation.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Review finds no permanent solution for female hair loss.

Nanotechnology shows promise for better hair loss treatments but needs more research for safety and effectiveness.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Dexpanthenol helps human hair follicle cells grow by preventing aging and death, and by supporting growth signals.

Trichoscopy is a useful non-invasive method to diagnose female hair loss with high accuracy.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.